Alma Solis
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Neonatal Respiratory Health Research, Pediatric health and respiratory diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Most-Cited Works
- → TLR5 participates in the TLR4 receptor complex and promotes MyD88-dependent signaling in environmental lung injury(2020)76 cited
- → Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis(2024)2 cited
- → Author response: TLR5 participates in the TLR4 receptor complex and promotes MyD88-dependent signaling in environmental lung injury(2020)1 cited
- → TLR5 Protects Against Pulmonary Fibrosis(2020)
- A case of pleuro-pulmonary actinomycosis.(1942)
- → TLR5 Participates in the TLR4 Receptor Complex and Biases Towards MyD88-Dependent Signaling in Environmental Lung Injury(2019)
- → Review for "Immunomodulatory metabolites in <scp>I</scp>g<scp>E</scp>‐mediated food allergy and oral immunotherapy outcomes based on metabolomic profiling"(2024)
- → Microbiome Protects Against Pulmonary Fibrosis Through TLR5 Activation(2019)